LYNDIBULIN
Dead / Abandoned — Abandoned — no statement of use filed (as of 14 Jan 2013)
What this means for you
This application is over — abandoned 14 Jan 2013. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 85329654
- Mark type
- Stylized text
- Filed
- 25 May 2011
- Published for opposition
- 18 Oct 2011
- Abandoned
- 14 Jan 2013
- Attorney of record
- Michael J. Bevilacqua, Esquire
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for the treatment of cancer
Owner
- ZIOPHARM Oncology, Inc., Boston, MA, US
- ZIOPHARM Oncology, Inc., Boston, MA, US
Prosecution history
- 14 Jan 2013 — ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
- 14 Jan 2013 — ABANDONMENT - NO USE STATEMENT FILED
- 06 Jul 2012 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Jul 2012 — SOU EXTENSION 1 GRANTED
- 08 Jun 2012 — SOU EXTENSION 1 FILED
- 29 Jun 2012 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 08 Jun 2012 — SOU TEAS EXTENSION RECEIVED
- 13 Dec 2011 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 18 Oct 2011 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 Oct 2011 — PUBLISHED FOR OPPOSITION
- 12 Sept 2011 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 12 Sept 2011 — ASSIGNED TO EXAMINER
- 22 Jul 2011 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 22 Jul 2011 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 31 May 2011 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED